Advarra
Advarra provides regulatory, ethics review, and clinical research technology solutions that support pharmaceutical companies, biotech firms, contract research organizations, and research sites in designing, approving, and managing clinical trials while maintaining compliance with global regulations. The company operates institutional review boards (IRBs) and offers software and services for study startup, site management, and research oversight. Advarra generates revenue through subscription software, technology-enabled services, and professional consulting to sponsors and research institutions.
- Revenue
- $250M - $1B
- Employees
- 1,001 - 5,000
- Founded
- 2017
- Headquarters
- Columbia, United States of America
Advarra customers on Arbolus
Customers who reviewed Advarra
Seniority of Advarra customers
The largest groups of people who reviewed Advarra hold Director and C-Suite roles (42% each), followed by Manager (15%).
- Director 42%
- C-Suite 42%
- Manager 15%
Customers sample
Employer names and spend open in the full report, along with the other 30 customers.
What 33 Arbolus experts think of Advarra
Overall sentiment: Positive
NPS scores are strongly positive, with most respondents rating 8–10 and only one rating below 7. Renewal intent is high among larger, more established customers and moderate in pilot or lower spend scenarios. Most respondents are in the more-than-a-year implementation stage, indicating mature adoption and stickiness, with a small fraction still piloting. Key expert themes are strong regulatory reliability, efficient review processes, and platform flexibility. Challenges revolve around cost and occasional delays.
Everything 33 customers told us about Advarra.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
24 Net Promoter Score, from 33 scored reviews- Promoters 13
- Passives 15
- Detractors 5
Praised
- Integrated Platform for Diverse Needs
- Structured and Centralized Review
- Efficiency and Consistency
- Enterprise Negotiation and Pricing Flexibility
Criticised
- Increasing Price with Platform Expansion
- Review Turnaround Challenges
- Accumulating Costs
- Technology Adoption Outpacing Human Oversight
What Advarra customers say
Integrated Platform for Diverse Needs
“Advarra integrates technology and talent to create a one-stop shop that serves sponsors, clinical sites, and other stakeholders for various clinical requirements.”
Structured and Centralized Review
“Using a centralized IRB like Advarra provides a structured and consistent review process, which is essential for human subject research.”
Efficiency and Consistency
“Advarra's consistency in the review process and efficient turnaround times are valuable, especially when supporting both initial study reviews and amendments.”
Renewal intent
Plan to renew 79%Plan to renew, by seniority
- 83% 6 answers
- 80% 5 answers
- 67% 3 answers
- 7.5/10 Average score from customers who will renew
- 7.7/10 Average score from undecided customers
Top alternatives
Most weighed by Advarra customersReport
For people who use Advarra
Do you use Advarra at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 33 customers of Advarra have already contributed
Takes a few minutes. Your identity stays anonymous.